A phase I study of GKT-771
Phase of Trial: Phase I
Latest Information Update: 27 Jul 2017
At a glance
- Drugs GKT 771 (Primary)
- Indications Cancer; Inflammation; Pain
- Focus Adverse reactions
- 27 Jul 2017 According to a GenKyoTex media release, this study is anticipated to start at the end of 2017.
- 02 Jan 2017 New trial record
- 22 Dec 2016 According to a GENTICEL, media release, the company expects to initiate this study in the second half of 2017.